NCT04634630View on ClinicalTrials.gov

The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

October 17, 2020

Study Completion Date

October 17, 2020

Conditions
Lung Cancer, Nonsmall CellRelapse/RecurrenceCSC
Interventions
GENETIC

Exposure to lung cancer stem cells

The exposure to lung cancer stem cells was measure as the percentage of Aldehyde dehydrogenase (ALDH) on all viable cells extracted from surgically resected tumor specimens

Trial Locations (1)

41124

Azienda Ospedaliero-Universitaria di Modena, Modena

All Listed Sponsors
lead

Beatrice Aramini

OTHER

NCT04634630 - The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung | Biotech Hunter | Biotech Hunter